18-crown-6

We are 18-crown-6 CAS:17455-13-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  18-crown-6
CAS.NO: 17455-13-9
Molecular Formula: C12H24O6
Molecular Weight: 264.31500

Synonyms:
1,4,7,10,13,16-Hexaoxacyclooctadecane
[18]crown-6
18-Crown-6
18-Crown 6-Ether
18-Crown ether-6
CROWN-18-5-ETHER

Physical and Chemical Properties:
Density: 1,175 g / cm3
Boiling point: 116 ° C 0,2mm
Melting point: 42-45 ° C (lit.)
Flash point:> 230 ° F
Refractive index: 1.4577 (50ºC)

Specification:
Appearance: White to almost white crystalline powder
Purity:≥99.0%
Water:≤0.1%
Heavy metals:≤0.002%
Sulphated ash:≤0.1%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 0-5ºC.The storeroom is ventilated and dry at low temperature, and it is not easy to store for a long time to prevent the generation of peroxides.
Application:  
High-efficiency phase transfer catalyst for fine organic synthesis, complexing agent, extraction agent for separation and extraction of noble metal and rare earth element.In chemical analysis, it is used in enrichment, separation and masking of ion.It also can be used as ion conducting materials and LCD component materials in medicine, biochemistry and electronic industry.

Related News: As United Airlines said when suspended flights to Beijing, Shanghai and Chengdu, the decision was made “due to the continued drop in demand for travel to China and the US Department of State’s decision to raise its China travel advisory to a Level 4.”3-Bromo-5-iodopyridine As United Airlines said when suspended flights to Beijing, Shanghai and Chengdu, the decision was made “due to the continued drop in demand for travel to China and the US Department of State’s decision to raise its China travel advisory to a Level 4.”2-amino-1-phenylethanone Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.32943-25-2 Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday.